1. 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study. Issue 8 (August 2022) Authors: Malaba, Thokozile R; Nakatudde, Irene; Kintu, Kenneth; Colbers, Angela; Chen, Tao; Reynolds, Helen; Read, Lucy; Read, Jim; Stemmet, Lee-Ann; Mrubata, Megan; Byrne, Kelly; Seden, Kay; Twimukye, Adelline; Theunissen, Helene; Hodel, Eva Maria; Chiong, Justin; Hu, Nai-Chung; Burger, David; Wang, Duol... Journal: Lancet Issue: Volume 9:Issue 8(2022) Page Start: e534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetics of levonorgestrel and etonogestrel contraceptive implants over 48 weeks with rilpivirine- or darunavir-based antiretroviral therapy. (5th September 2022) Authors: Nakalema, Shadia; Chappell, Catherine A; Pham, Michelle; Byakika-Kibwika, Pauline; Kaboggoza, Julian; Walimbwa, Stephen I; Musaazi, Joseph; Nakijoba, Ritah; Mbabazi, Leah; Kyohairwe, Isabella; Nassiwa, Sylvia; Jeppson, Jeffrey; Winchester, Lee; Siccardi, Marco; Fletcher, Courtney V; Scarsi, Kimbe... Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 11(2022) Page Start: 3144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗